Literature DB >> 32816248

Distributions of serum thyroid-stimulating hormone in 2020 thyroid disease-free adults from areas with different iodine levels: a cross-sectional survey in China.

B Ren1, S Wan1,2, L Liu1, M Qu1, H Wu1, H Shen3.   

Abstract

PURPOSE: The aim of the present study was to describe the distributions of serum thyroid- stimulating hormone (TSH) levels in thyroid disease-free adults from areas with different iodine levels in China. Meanwhile, we aimed to evaluate the influence of age and gender on the distribution of TSH, assess the relationship between concentrations of TSH and free thyroxine (FT4), and analyze the factors that may affect TSH levels.
METHODS: 2020 adults were included from April 2016 to June 2019. Urinary iodine concentration, serum iodine concentration, serum TSH, FT4, free triiodothyronine, thyroid peroxidase antibodies and thyroglobulin antibodies were measured, and thyroid ultrasonography was performed.
RESULTS: The median of TSH in iodine-fortification areas (IFA), iodine-adequate areas (IAA), iodine-excessive areas (IEA) were 2.32, 2.11 and 2.34 mIU/L, respectively. Serum TSH concentrations were significantly higher in IFA and IEA than that in IAA (p = 0.005 and < 0.0001). The TSH values of most adults were distributed within the range of 1.01-3.00 mIU/L with the same trend in three groups. In our study, TSH levels did not change with age, and the TSH level of females was higher than that of males (p < 0.0001). There was a negative correlation between FT4 and TSH in IAA (r = - 0.160, p < 0.0001) and IEA (r = - 0.177, p < 0.0001), but there was no correlation between FT4 and TSH in IFA (r = - 0.046, p = 0.370). BMI, smoking status, education levels, and marital status were associated with TSH.
CONCLUSION: Our study provides a basis for establishing the reference intervals of TSH in different iodine level areas.

Entities:  

Keywords:  Iodine level; Population study; Reference intervals; TSH

Year:  2020        PMID: 32816248     DOI: 10.1007/s40618-020-01395-2

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  35 in total

1.  Epidemiological survey on the relationship between different iodine intakes and the prevalence of hyperthyroidism.

Authors:  Fan Yang; Weiping Teng; Zhongyan Shan; Haixia Guan; Yushu Li; Ying Jin; Fengnan Hu; Xiaoguang Shi; Yajie Tong; Wei Chen; Bai Yuan; Zhanyi Wang; Bingyuan Cui; Shiming Yang
Journal:  Eur J Endocrinol       Date:  2002-05       Impact factor: 6.664

2.  Reference intervals for serum thyrotropin (TSH) and free thyroxine (FT4) in adults using the Access Immunoassay System.

Authors:  Michèle d'Herbomez; Véronique Jarrige; Claude Darte
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

3.  An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits.

Authors:  Laura Boucai; Joseph G Hollowell; Martin I Surks
Journal:  Thyroid       Date:  2010-11-08       Impact factor: 6.568

4.  Reference interval by the indirect approach of serum thyrotropin (TSH) in a Mediterranean adult population and the association with age and gender.

Authors:  Bruna Lo Sasso; Matteo Vidali; Concetta Scazzone; Luisa Agnello; Marcello Ciaccio
Journal:  Clin Chem Lab Med       Date:  2019-09-25       Impact factor: 3.694

Review 5.  Consequences of iodine deficiency and excess in pregnant women: an overview of current knowns and unknowns.

Authors:  Elizabeth N Pearce; John H Lazarus; Rodrigo Moreno-Reyes; Michael B Zimmermann
Journal:  Am J Clin Nutr       Date:  2016-08-17       Impact factor: 7.045

Review 6.  Age- and race-based serum thyrotropin reference limits.

Authors:  Martin I Surks; Laura Boucai
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

7.  Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism.

Authors:  Martin I Surks; Joseph G Hollowell
Journal:  J Clin Endocrinol Metab       Date:  2007-10-02       Impact factor: 5.958

8.  The relationship between iodine nutrition and thyroid disease in lactating women with different iodine intakes.

Authors:  Lixiang Liu; Dandan Wang; Peng Liu; Fangang Meng; Da Wen; Qingzhen Jia; Jun Liu; Xiaoye Zhang; Peng Jiang; Hongmei Shen
Journal:  Br J Nutr       Date:  2015-09-14       Impact factor: 3.718

9.  Iodine deficiency and excess coexist in china and induce thyroid dysfunction and disease: a cross-sectional study.

Authors:  Yang Du; Yanhui Gao; Fangang Meng; Shoujun Liu; Zhipeng Fan; Junhua Wu; Dianjun Sun
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

10.  Iodine Intake is Associated with Thyroid Function in Mild to Moderately Iodine Deficient Pregnant Women.

Authors:  Marianne Hope Abel; Tim I M Korevaar; Iris Erlund; Gro Dehli Villanger; Ida Henriette Caspersen; Petra Arohonka; Jan Alexander; Helle Margrete Meltzer; Anne Lise Brantsæter
Journal:  Thyroid       Date:  2018-10       Impact factor: 6.568

View more
  3 in total

1.  Effect of different iodine levels on the DNA methylation of PRKAA2, ITGA6, THEM4 and PRL genes in PI3K-AKT signaling pathway and population-based validation from autoimmune thyroiditis patients.

Authors:  Bingxuan Ren; Siyuan Wan; Huaiyong Wu; Mengying Qu; Yao Chen; Lixiang Liu; Meihui Jin; Zheng Zhou; Hongmei Shen
Journal:  Eur J Nutr       Date:  2022-05-27       Impact factor: 4.865

2.  Indirect estimation of reference intervals for thyroid parameters using advia centaur XP analyzer.

Authors:  Bosa Mirjanić-Azarić; Neda Milinković; Natasa Bogavac-Stanojević; Sanja Avram; Tanja Stojaković-Jelisavac; Darja Stojanović
Journal:  J Med Biochem       Date:  2022-04-08       Impact factor: 2.157

3.  Reference Intervals for Serum Thyroid-Stimulating Hormone Based on a Recent Nationwide Cross-Sectional Study and Meta-Analysis.

Authors:  Xichang Wang; Yongze Li; Xiaodan Zhai; Haoyu Wang; Fan Zhang; Xiaotong Gao; Shengyu Liu; Weiping Teng; Zhongyan Shan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-01       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.